Lutronic LaseMD for Treatment of Benign Pigmented Lesions

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 17, 2017

Primary Completion Date

December 20, 2018

Study Completion Date

February 25, 2019

Conditions
Benign Pigmented Lesions
Interventions
DEVICE

LaseMD and DUAL 1927nm Laser

Laser treatment of benign pigmented lesion based on photothermolysis whereby the target molecule, the chromophore, absorbs a delivered wavelength of light over a period of time to damage the target while limiting collateral damage to adjacent structures, leading to pigmentary clearance.

DEVICE

LaseMD

Laser treatment of benign pigmented lesion using optimized treatment settings.

Trial Locations (2)

21030

Maryland Dermatology Laser, Skin & Vein Institute, Hunt Valley

28207

Dermatology, Laser, and Vein Specialists of the Carolinas, Charlotte

Sponsors
All Listed Sponsors
lead

LUTRONIC Corporation

INDUSTRY

NCT03409952 - Lutronic LaseMD for Treatment of Benign Pigmented Lesions | Biotech Hunter | Biotech Hunter